tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Compare Coherus Biosciences (CHRS) vs. Competitors

Compare
1,649 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Coherus Biosciences
$2.22
$268.33M
91.38%
4 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$4.11
$544.13M
-13.31
156.38%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protalix
$2.73
$233.22M
41.73
15.08%
1 Buy
0 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$15.63
$123.30M
22.45
-15.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma
$1.76
$168.15M
-2.98
-8.72%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CHRS
Coherus Biosciences
2.22
1.02
85.00%
SLS
SELLAS Life Sciences Group
3.82
2.32
154.67%
PLX
Protalix
2.90
0.23
8.61%
MCRB
Seres Therapeutics
13.63
-2.18
-13.79%
GNFT
IPHA
Innate Pharma
1.78
-0.17
-8.72%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts